Indonesia vs Uzbekistan: Average non-HDL cholesterol levels
Indonesia
3.6
in 2018
Uzbekistan
3.6
in 2018
Indonesia rank
30th
Uzbekistan rank
30th
Average non-HDL cholesterol levels over time
- Indonesia
- Uzbekistan
How they compare
Indonesia currently reports 3.6 against 3.6 in Uzbekistan, a difference of 0.
The two have swapped places 6 times across 39 shared years of data; in 1980 it was Uzbekistan ahead.
Indonesia ranks 30th and Uzbekistan ranks 30th of 191 countries.
Across the 4 decades both report, Indonesia averaged higher in 1 and Uzbekistan in 3.
Head to head by decade
| Decade | Indonesia | Uzbekistan | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 2.9 | 3.32 | 0.42 | Uzbekistan |
| 1990s | 2.93 | 3.15 | 0.22 | Uzbekistan |
| 2000s | 3.15 | 3.19 | 0.04 | Uzbekistan |
| 2010s | 3.5 | 3.46 | 0.0444 | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average non-hdl cholesterol levels, Indonesia or Uzbekistan?
- Indonesia, at 3.6 against 3.6 in Uzbekistan as of 2018.
- What is the difference in average non-hdl cholesterol levels between Indonesia and Uzbekistan?
- 0, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Uzbekistan?
- 39 years are reported by both, from 1980 to 2018.
- How do Indonesia and Uzbekistan rank globally for average non-hdl cholesterol levels?
- Indonesia ranks 30th and Uzbekistan ranks 30th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated average level of non-high-density lipoprotein (non-HDL) cholesterol, commonly known as "bad cholesterol". Healthy levels are considered to be under 4mmol/L. Elevated levels of non-HDL cholesterol are a risk factor for chronic complications, including cardiovascular disease, and premature death.